Workup for Viral Myositis in Pediatric Patients
For benign acute childhood myositis (BACM), the typical viral myositis presentation, minimal laboratory workup is needed—obtain creatine phosphokinase (CPK) and urine myoglobin, with additional testing reserved only for severe or atypical cases.
Initial Clinical Assessment
The diagnosis of viral myositis in children is primarily clinical, focusing on:
- Bilateral calf pain with refusal to walk or abnormal gait (tiptoe walking) in a school-aged child (median age 6-7 years) 1, 2
- Recent viral illness (within 3 days), particularly upper respiratory infection with fever, cough, or sore throat 1, 3
- Male predominance (approximately 65-76% of cases) 1, 2
- Normal neurological examination is essential—any neurological abnormalities suggest alternative diagnoses 2
Essential Laboratory Workup
For Typical BACM Presentation:
- CPK level: Expect median elevation of 1400-1800 U/L (normal <150 U/L); this is the primary diagnostic test 1, 2
- Urine myoglobin: Screen for rhabdomyolysis risk, though myoglobinuria is uncommon 4, 3
- Viral studies: Consider testing for influenza A/B and SARS-CoV-2, as these are most commonly associated 1, 5
No further investigation is typically needed for classic presentations 3.
Extended Workup for Severe or Atypical Cases
Indications for Additional Testing:
Pursue comprehensive workup when encountering:
- Marked CPK elevation ≥5000 U/L 1
- Recurrent episodes of myositis 1
- Absence of rash but persistent symptoms (consider juvenile dermatomyositis) 6
- Atypical presentation (asymmetric involvement, prolonged course, systemic features) 6
Comprehensive Laboratory Panel (Based on JDM Guidelines):
When atypical features are present, obtain 6:
- Complete blood count with differential
- ESR and CRP for inflammatory markers
- Liver function tests (AST, ALT, LDH—also serve as muscle enzymes)
- Renal function tests and electrolytes
- Thyroid function tests to exclude endocrine myopathy
- Vitamin D level (deficiency can cause myopathy)
- Myositis-specific and myositis-associated antibodies if dermatomyositis suspected
Advanced Investigations for Persistent or Severe Cases:
- MRI of muscles using T2-weighted/STIR sequences to detect inflammation—useful when diagnosis is uncertain 6
- Muscle biopsy (open or needle) if presentation lacks typical features or rash is absent; requires expert histopathological interpretation 6
- EMG/nerve conduction studies only if suspecting neuropathy or neuromuscular junction disorder 6
- Metabolic/mitochondrial myopathy screening via next-generation sequencing panel for recurrent cases or marked CPK elevation 1
Cardiac and Pulmonary Assessment
Not routinely indicated for typical viral myositis, but required if considering juvenile dermatomyositis 6:
- ECG and echocardiogram at diagnosis
- Pulmonary function tests with CO diffusion
- Chest X-ray or HRCT if pulmonary symptoms present
Key Clinical Pitfalls to Avoid
- Do not over-investigate typical BACM cases—this leads to unnecessary anxiety and healthcare costs 2, 3
- Monitor for myoglobinuria progression—though rare, it can cause renal impairment 4, 1
- Distinguish from dermatomyositis—examine carefully for rash (heliotrope, Gottron papules), perform nailfold capillaroscopy if available 6
- Consider admission if: CPK >5000 U/L, myoglobinuria present, inadequate oral intake, or social concerns about follow-up 1, 2
Expected Clinical Course
- CPK normalization: Median 7 days from peak 1
- Symptom resolution: Usually within 3 days 3
- Recurrence risk: Approximately 10% of patients; higher median CPK (2330 vs 1150 U/L) at initial presentation predicts recurrence 2
- Prognosis: Excellent with no residual muscular impairment in uncomplicated cases 2, 3
Seasonality Considerations
- Peak incidence: Winter months with secondary peak in autumn, correlating with influenza season 1
- Emerging etiology: SARS-CoV-2 now recognized as causative agent, with trend toward higher hospitalization rates compared to influenza 1, 5
- Longer fever-to-symptom interval predicts greater symptom severity 5